Cinnamon
Dietary Supplement2.8g/day of cinnamon in capsules during 4 weeks.
NCT Number: NCT01085019
The general objective of the study is to investigate the effects of the daily consumption of spices and herbs for four (4) consecutive weeks in endothelial function and cardiovascular risk factors of men and postmenopausal women.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Not applicable
Richardson Centre of Functional Foods and Nutracuticals, Winnipeg, Manitoba, Canada
The purpose is to assess whether the polyphenol/antioxidant content of different spices will affect endothelial function and other cardiovascular risk factors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2.8g/day of cinnamon in capsules during 4 weeks.
2.8g/day of oregano in capsules during 4 weeks.
2.8g/day of ginger in capsules during 4 weeks.
2.8g/day of rosemary in capsules during 4 weeks.
2.8g/day of black pepper in capsules for 4 weeks.
2.8 g/day of placebo in capsules (corn starch) during 4 weeks.
Time frame: at week 0 and week 4
Time frame: at week 0 and week 4
Time frame: at week 0 and week 4
Time frame: at week 0 and week 4
Laval University
Other
Investigation of the Impact of Spices and Herbs on Endothelial Function and Other CVD Risk Factors in Men and Women.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05451641
Endothelial Function
Austin, Texas, United States
View Trial DetailsNCT06288828
Aerobic Exercises, Atrophy
Bangkok, Thailand
View Trial DetailsNCT07544186
COVID-19, Chronic Disease
Mexico City, Mexico
View Trial DetailsNCT04971408
Central Nervous System Diseases, Chronic Inflammation
San Antonio, Texas, United States
View Trial Details